National MS society awards research grant to Anneli Peters and Lisa-Ann Gerdes
Klaus Faber Initiative for Progressive MS funded at the Institute of Clinical Neuroimmunology
January 2022: Our group leaders Anneli Peters and Lisa Ann Gerdes won a highly competitive research grant of 297.000 USD from the US-American National Multiple Sclerosis Society (NMSS).
November 2021: The Klaus Faber foundation has funded a new research initiative at the Institute of Clinical Neuroimmunology that aims to uncover disease driving mechanisms in multiple sclerosis.
MS discordant monozygotic twins help to untangle environmental and genetic influences in immune profiles
PET imaging can improve montoring of Natalizumab-associated PML
February 2022 – MS discordant monozygotic twins help to untangle environmental and genetic influences in immune profiles. The Beltrán and Gerdes labs studied the immune profiles in the MS TWIN STUDY to differentiate the influence of the environment and genetics in multiple sclerosis. In collaboration with the Becher lab from...
November 2021 – Progressive multifocal leukoencephalopathy (PML) is a severe CNS infection that can occur in MS patients treated with Natalizumab. Clinical management of patients with Natalizumab-associated PML is challenging not least because imaging...